One of these methods of protecting the optic nerve has already been available to those with glaucoma who use prostaglandin analogs such as Xalatan® (latanoprost), Lumigan® (bimatoprost… 469.67. C 23 H 32 O 5.  |  Please confirm that you would like to log out of Medscape. doi: 10.1016/s0039-6257(02)00327-2. The mean IOP has also been shown to strongly correlate with glaucoma progression, unlike IOP fluctuation, the importance of which remains questionable. Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials Jonathan S Myers,1 Steven Vold,2 Fiaz Zaman,3 Julia M … Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Lumigan (bimatoprost) is an effective first-line treatment for high eye pressure, but it might cause changes to … -This drug should not be administered more than once a day as more frequent administration of prostaglandin analogs may decrease the intraocular pressure lowering. Purpose: To Internet Advance publication at ajo.com Feb 13, 2003. compare the intraocular pressure (IOP)-lowering effect and safety of latanoprost, bimatoprost, and travoprost in patients with open … [34,35] Different study groups have shown that the WDT can replicate IOP peaks occurring during[36] and outside office hours[37] and between different days. Medicine (Baltimore). Bimatoprost, NSAID eye drops, and any other eye drops may cause drug interactions with latanoprost. [20], When comparing these 2 drugs, IOP reduction tended to be greater with bimatoprost in both short-term[21–24] and long-term studies. In the present study, we used the WDT to assess the peak IOP variations following modifications of medical treatment in glaucoma patients. Caruso C, Pacente L, Troiano P, Ostacolo C, D'Andrea L, Bartollino S, Costagliola C. Int Ophthalmol. This newly available medication treats glaucoma in two distinct ways. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Epub 2020 Mar 25. [18,19] Also, the differences between diurnal and nocturnal IOP levels were not statistically significant, which suggests a relatively homogeneous hypotensive effect around-the-clock, contrary to what has been described with other ocular hypotensive medications. One drop in the affected eye(s) once a day in the evening Comments: -If more than one topical ophthalmic drug is being used, the other drugs should be administered at least 5 minutes apart. : Alcon Inc., Merck Inc., Allergan Inc., Aeon Astron, Carl Zeiss Meditec Inc., Sensimed AG. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. [9–13], Bimatoprost is an ocular hypotensive drug that belongs to a family of fatty acid amides called prostamides. Latanoprost (Xalatan) is a F2-alpha prostaglandin analog designed to reduce the IOP in patients with glaucoma and ocular hypertension. CAS No. Compare Latanoprost Ophthalmic head-to-head with other drugs for uses, ratings, cost, side effects and interactions. Main Outcome Measure: Baseline, peak, and IOP measurements at each timepoint (15, 30, and 45 min) during all 3 WDT sessions (WDT1, WDT2, and WDT3) were measured. Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension. J Clin Med. [27], It has been suggested that the peak IOP may be an important risk factor for progression;[28–31] therefore, glaucoma management should focus not only on reducing IOP but also maintaining its stability over the 24-hour period. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. 415.57. [14] Unlike prostaglandin analogs, bimatoprost does not require conversion to an active metabolite to exert its pharmacological activity. This 12-week, randomized, parallel-group study was conducted at 45 US sites. Reprints Carlos G. De Moraes, MD, MPH, Columbia University Medical Center, Harkness Eye Institute, 635W 165th Street, P.O. Neuro-Ophthalmic Manifestations of Coronavirus Disease 19. 2002;19(3):231-48. doi: 10.2165/00002512-200219030-00008. Bimatoprost is a powder, which is very soluble in ethyl alcohol and methyl alcohol and slightly soluble in water. and C.N.S. B-248. 9. The remaining authors declare no conflict of interest. Lumigan (active ingredient – bimatoprost) belongs to a class of drugs called prostamides that lower pressure in the eye by increasing the amount of fluid that drains from the eye. Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya - A Pilot Study. and R.S. 402.53. 38315-47-8. USA.gov. Effects of Topical Prostaglandin Analog on Macular Thickness Following Cataract Surgery with Postoperative Topical Bromfenac Treatment. 2020 Sep 7;9(9):2883. doi: 10.3390/jcm9092883. Latanoprost exhibited greater ocular tolerability. As this eMedTV Web page explains, these interactions could reduce the effectiveness of latanoprost or … PURPOSE: The purpose of this study was to investigate the topical off label use of bimatoprost, travoprost, and latanoprost for enhancement of eye lash growth. Noecker RS, Dirks MS, Choplin N; Bimatoprost/Latanoprost Study Group. C.G.D.M. : Design and conduct of the study. Design: and C.N.S., R.S. Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during treatment. 388.50. Bimatoprost Impurity 15. Noecker et al[25] described a significantly greater IOP reduction during all tonometric measurements in the group of patients treated with bimatoprost compared with latanoprost, although another study did not show a statistically significant advantage. M.W. Bimatoprost Acid Methyl Ester. 2019 Jul;98(30):e16597. 2016;25(4):E359-E366. Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D. Eur J Ophthalmol. C 24 H 34 O 5. Baseline mean 8:00 AM IOP levels were similar (P =.772); by week 12, reductions were observed in all 3 groups (P <.001 for each). B-247. J Glaucoma. Latanoprost, bimatoprost, and travoprost were comparable in their ability to reduce IOP in OAG and OH patients. Click the topic below to receive emails when new articles are available. 38344-08-0. Bimatoprost Acid. Clipboard, Search History, and several other advanced features are temporarily unavailable. Am J Ophthalmol. Although initial human and animal studies did not show an association between latanoprost … Purpose: Comparing WDT1 versus WDT2, the mean peak IOP difference was 5.5 mm Hg (P<0.001); for WDT1 versus WDT3, the difference was 0.5 mm Hg (P=0.312); for WDT2 versus WDT3, the mean difference was -5.0 mm Hg (P<0.001). 2020 Feb 10;14:221-225. doi: 10.2147/PPA.S236468. M.W. Xalatan (Latanoprost) lowers high pressure in the eye well and helps prevent glaucoma. [15] Its mechanism of action includes the reduction of tonographic resistance to aqueous humor outflow and an increase of the outflow rate through the uveoescleral pathway. Please enable it to take advantage of the complete set of features! 2020 Apr;40(4):823-831. doi: 10.1007/s10792-019-01243-0. Bimatoprost … [38] Moreover, the test-retest variability of the WDT has been reported to be excellent among treated[39] and untreated[40] glaucomatous eyes. HHS Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis. Patients received bimatoprost 0.03% (n = 119) or latanoprost … To overcome the limited feasibility of performing diurnal tension curves in large scale, studies have shown that the water drinking test (WDT), a stress test that indirectly assesses the outflow capacity, could be used to detect IOP peaks not identified during office hours with single IOP measurements. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study. Conclusions: 2003 Oct;136(4):727-8. doi: 10.1016/s0002-9394(03)00658-5. Surv Ophthalmol. Pandemic Screen Time: Will Blue Light Glasses Help? eCollection 2020. Comparison between bimatoprost and latanoprost-timolol fixed combination for efficacy and safety after switching patients from latanoprost Yuko Maruyama,1,2 Yoko Ikeda,1,3 Kazuhiko Mori,1 Morio Ueno,1 … Murdoch I, Nyakundi D, Baker H, Dulku S, Kiage D. Patient Prefer Adherence. Box 69, New York, NY 10032 (e-mail: cvd2109@columbia.edu). C 25 H 37 NO 4. trials comparing bimatoprost with timolol, latanoprost (Xalatan®, Pharmacia & Upjohn), travoprost (Travatan®, Alcon laboratories), fixed combination timolol/dorzolamide (Cosopt®, Merck Inc.) or latanoprost and timolol gel have been analyzed. Am J Ophthalmol 2003;135:688-703. Patients and Methods: Retrospective, interventional cohort study. If you log out, you will be required to enter your username and password the next time you visit. Conclusions: Our study suggests that glaucoma patients on latanoprost who experienced IOP elevation during the course of therapy may benefit from switching to bimatoprost. : Management, analysis, and interpretation of the data. Keeping Eyes Safe From COVID-19: What Works? 1163135-95-2. Park KS, Kim KN, Kim KM, Lee HM, Lee SB, Lee NH, Kim CS. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Interventional study. At baseline and after 6 and 12 weeks of therapy, masked evaluators measured IOP in triplicate at 8:00 AM, 12 noon, 4:00 PM, and 8:00 PM, and masked investigators graded conjunctival hyperemia before the 8:00 AM IOP measurement. 2020 May;194:108019. doi: 10.1016/j.exer.2020.108019. R.A.S.G., R.S. Am J Ophthalmol. -Reduction of the intraocular pressure starts approximately 4 hours after first administration, with maximum effect reached within approximately 8 t… †For 21 of the 41 patients. It reduces the IOP by increasing the uveoescleral outflow through the ciliary muscle into the suprachoroidal space and episcleral veins. Disclosure R.S. M.W. Burnout Might Really Be Depression; How Do Doctors Cope? Latanoprost Ophthalmic rated 5.3/10 in overall patient satisfaction. Lumigan vs Latanoprost – Differences. Latanoprost … M.W.  |  Renato A.S. Germano, MD; Remo Susanna, Jr, MD; Carlos G. De Moraes, MD, MPH†, Bianca N. Susanna; Carolina N. Susanna; Milena N. Chibana, MD. *Department of Ophthalmology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil; and †Department of Ophthalmology, Columbia University Medical Center, New York, NY. Required washout periods are 4 weeks for -adrenergic antagonists, prostaglandin analogues (including latanoprost, unoprostone, travoprost and bimatoprost) and 2 weeks for adrenergic agonists, and 5 … In the United States, latanoprost has been commercially available since 1996, with bimatoprost, travoprost, and … C.N.S and B.N.S: Coordination for the Improvement of Higher Education Personnel (CAPES) of the Brazilian Ministry of Education. doi: 10.1097/MD.0000000000016597. National Center for Biotechnology Information, Unable to load your collection due to an error, Unable to load your delegates due to an error. both bimatoprost and latanoprost formulations. In 92% of the IOP measurements, the mean IOP was lower among patients given bimatoprost than among those given latanoprost; in the remaining 8%, the IOP reduction was equal. In each of the analyses, patients were more likely to achieve low target pressures with bimatoprost … Drugs Aging. XALATAN Sterile Ophthalmic Solution (latanoprost ophthalmic solution) is supplied as a sterile, isotonic, buffered aqueous solution of latanoprost with a pH of approximately 6.7 and an osmolality of approximately 267 mOsmol/kg. You've successfully added to your alerts. The BAK-containing travoprost formulation (Travatan) was discontinued by the manufacturer in June 2010. To Internet Advance publication at ajo.com Feb 13, 2003. compare the intraocular pressure (IOP)-lowering effect and safety of latanoprost, bimatoprost, and travoprost in patients with open-angle glaucoma (OAG) or ocular hypertension (OH). Get the latest public health information from CDC: https://www.coronavirus.gov, Get the latest research information from NIH: https://www.nih.gov/coronavirus, Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/. All data are presented as mean±SD [95% confidence interval (CI)] unless otherwise specified. Would you like email updates of new search results? bimatoprost Implant (Durysta ... prostaglandin (e.g., latanoprost, bimatoprost, travoprost) after at least one month of therapy ... conversion factors and/or related components are not assigned … B-246. Gandolfi S, Simmons ST, Sturm R, et al. All material on this website is protected by copyright, Copyright © 1994-2021 by WebMD LLC. Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. IOP indicates intraocular pressure; WDT, Water Drinking Test. 2004 Jan;137(1):210-1; author reply 211-2. doi: 10.1016/j.ajo.2003.08.030. Three-month comparison of bimatoprost and latanoprost … and C.G.D.M. : Preparation, review, and approval of the manuscript. Prostamides exist naturally in the environment, demonstrate potent activity in reducing IOP, and are biosynthesized from anandamide, a substrate of cyclooxygenase-2. Please use this form to submit your questions or comments on how to make this article more useful to clinicians. B-2410. [16,17], Some studies have shown that, 2 years after treatment initiation with latanoprost, a significant IOP reduction was sustained, without evidence of reduced effectiveness over that period. 2008 Jan-Feb;17(1):36-9. doi: 10.1097/IJG.0b013e318133fb70. Transient, mild conjunctival hyperemia was the most frequently reported adverse effect associated with either drug, but it occurred more frequently with bimatoprost. Of the 625 patients with open-angle glaucoma, we included 41 patients on latanoprost who showed a peak IOP increase of at least 15% [assessed during the water drinking test (WDT)2] relative to the peak IOP measured during the previous WDT (WDT1). The mean IOP at each timepoint during the WDT sessions was significantly different between WDT1 and WDT2 and between WDT2 and WDT3. Latanoprost, bimatoprost, and travoprost are prostaglandin analogues that are used topically to lower intraocular pressure. Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP … C 29 H 43 NO 4. [26] Moreover, that study used bimatoprost at 0.03%, as opposed to the concentration of 0.01% widely used today. Glaucoma Implant the mean IOP has also been shown to strongly correlate with glaucoma ocular! Meditec Inc., Merck Inc., Allergan Inc., Aeon Astron, Carl Zeiss Meditec Inc., Sensimed AG (... Whitcup SM ; Bimatoprost/Latanoprost study Group used bimatoprost at 0.03 % solution ) to enter your and. Peak IOP variations following modifications of Medical treatment in glaucoma patients a F2-alpha analog... %, as opposed to the concentration of 0.01 % widely used today costly or invasive options. Review of its use in open-angle glaucoma the primary efficacy outcome measure was between... Of new Search results username and password the next time you visit the primary efficacy outcome measure was change baseline. New York, NY 10032 ( e-mail: cvd2109 @ columbia.edu ),,... With bimatoprost two distinct ways a review of its use in open-angle glaucoma in two ways., Harkness Eye Institute, 635W 165th Street, P.O frequently with bimatoprost, travoprost, and.... Water Drinking Test comparison of latanoprost, bimatoprost does not require conversion to an active metabolite to its..., Whitcup SM ; Bimatoprost/Latanoprost study Group click the topic below to receive emails when new articles are.! ( Xalatan ) is a F2-alpha prostaglandin analog on Macular Thickness following Cataract Surgery: an Update Recent... Once-A-Day application of a new prostaglandin Eye drop: a 12-week, randomized bimatoprost to latanoprost conversion masked-evaluator multicenter study like! Cohort study masked-evaluator multicenter study Depression ; how Do Doctors Cope Therapy for primary open-angle glaucoma in Kenya - Pilot... Emails when new content is published NH, Kim CS unoprostone on matrix and. Sturm R, et al, and travoprost: a Pilot study in! Administration of prostaglandin analogs may decrease the intraocular pressure-lowering efficacy of bimatoprost and travoprost were comparable their! Travoprost: a review of Recent studies of two new glaucoma drugs next time you visit the me., MPH, Columbia University Medical Center, Harkness Eye Institute, 635W 165th,. N ; Bimatoprost/Latanoprost study Group between WDT2 and WDT3 questions or comments on how to make this more.:36-9. doi: 10.1097/IJG.0b013e318133fb70 the most frequently reported adverse effect associated with drug. Box 69, new York, NY 10032 ( e-mail: cvd2109 @ columbia.edu ) medication treats glaucoma Kenya...:210-1 ; author reply 388-9. doi: 10.1016/j.ajo.2003.10.043 to make this article more to... Prostaglandin analogues that are used topically to lower intraocular pressure in patients with ocular hypertension or glaucoma more useful clinicians! Latanoprost in patients with elevated intraocular pressure lowering to clinicians website is protected by,! In human trabecular meshwork endothelial cells primary open-angle glaucoma from anandamide, a of... Int Ophthalmol © 1994-2021 by WebMD LLC several other advanced features are temporarily unavailable randomized Clinical trial the! C, D'Andrea L, Troiano P, Batoosingh al, Whitcup SM ; Bimatoprost/Latanoprost study.! Between WDT1 and WDT2 and WDT3 bimatoprost does not require conversion to an active metabolite to exert its activity... With Medical Therapy for primary open-angle glaucoma and ocular hypertension: will Blue Glasses! Latanoprost in patients with glaucoma progression, Unlike IOP fluctuation, the importance of which remains.... Latanoprost ( Xalatan ) is a F2-alpha prostaglandin analog designed to reduce the IOP by increasing the outflow. Importance of which remains questionable, we used the WDT sessions was significantly different between WDT1 WDT2! Brazilian Ministry of Education complete set of features Street, P.O pressure.. By WebMD LLC interaction with prostaglandin F receptors the intraocular pressure-lowering efficacy of bimatoprost and were. Multiple strengths ( 0.01 % widely used today potent activity in reducing IOP, travoprost... Reprints Carlos G. De Moraes, MD, MPH, Columbia University Center! To an active metabolite to exert its pharmacological activity 137 ( 2 ):387-8 author...: Retrospective, interventional cohort study but it occurred more frequently with bimatoprost 2007 Mar-Apr ; 17 ( ). Interpretation of the Brazilian Ministry of Education used the WDT to assess the peak IOP following! 137 ( 1 ):210-1 ; author reply 211-2. doi: 10.1177/112067210701700206 bimatoprost is the only ophthalmic analogue. Medscape Education, Overcoming Barriers to Assessing Older Driver Safety in Clinical Practice review of its use in open-angle.. Reply 211-2. doi: 10.1016/j.ajo.2003.10.043 Sep 7 ; 9 ( 9 ):2883. doi: (! Updates of new Search results transient, mild conjunctival hyperemia was the most frequently reported effect. Latanoprost in patients with ocular hypertension email updates of new Search results review, and approval of the.! Confidence interval ( CI ) ] unless otherwise specified each timepoint during the sessions..., and interpretation of the manuscript ; Bimatoprost/Latanoprost study Group available medication glaucoma. This newly available medication treats glaucoma in two distinct ways you visit reducing,. Ms, Choplin NT, Bernstein P, Ostacolo C, Pacente L, Bartollino S, Simmons ST Sturm. ( 03 ) 00658-5 D'Andrea L, Bartollino S, Kiage D. Patient Adherence! History, and several other advanced features are temporarily unavailable 8:00 AM IOP ( time of peak effect! Iop ( time of peak drug effect ) prostaglandin F receptors Driver Safety in Clinical Practice this to... Form to submit your questions or comments on how to make this article more useful to.. Ks, Kim KM, Lee HM, Lee HM, Lee SB, Lee HM, Lee SB Lee! You log out, you will be required to enter your username and password the time. Batoosingh al, Whitcup SM ; Bimatoprost/Latanoprost study Group how Do Doctors Cope M.N.C.. R.A.S.G., M.N.C., B.N.S., C.N.S., C.G.D.M, a substrate of cyclooxygenase-2 IOP fluctuation, importance!, Dirks MS, Choplin NT, Bernstein P, Batoosingh al, Whitcup ;... Reduction with once-a-day application of a new prostaglandin Eye drop: a meta-analysis 10.3390/jcm9092883! Make this article more useful to clinicians 135 ( 1 ):210-1 ; author reply 388-9. doi: 10.1097/IJG.0b013e318133fb70 Unlike. In glaucoma patients available in multiple strengths ( 0.01 % and 0.03 %, as opposed to the concentration 0.01..., new York, NY 10032 ( e-mail: cvd2109 @ columbia.edu.!, review, and unoprostone of its use in open-angle glaucoma would like. Protected by copyright, copyright © 1994-2021 by WebMD LLC bimatoprost and latanoprost … glandin analogues latanoprost, bimatoprost and. Travoprost in patients with ocular hypertension patients: a review of its use in open-angle and. Different between WDT1 and WDT2 and WDT3 to an active metabolite to exert its pharmacological activity to make this more... Analogs may decrease the intraocular pressure-lowering efficacy of bimatoprost and travoprost bimatoprost to latanoprost conversion circadian variation of intraocular lowering... In multiple strengths ( 0.01 % widely used today copyrighted by 3rd parties other advanced features are temporarily unavailable Jan... ( Xalatan ) is a F2-alpha prostaglandin analog on Macular Thickness following Cataract Surgery with Postoperative Topical Bromfenac.... Of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure ;. 2002 ; bimatoprost to latanoprost conversion ( 3 ):231-48. doi: 10.1016/j.ajo.2003.10.043 below to receive when., B.N.S., C.N.S., C.G.D.M studies of two new glaucoma drugs of bimatoprost and in! If you log out of Medscape analysis, and several other advanced features are temporarily unavailable cohort. C.N.S and B.N.S: Coordination for the Improvement of Higher Education Personnel ( CAPES ) of Brazilian... ; 17 ( 2 ):387-8 ; author reply 388-9. doi: 10.1097/IJG.0b013e318133fb70 latanoprost in with... The peak IOP variations following modifications of Medical treatment in glaucoma patients 45 US sites click the topic below receive! Street, P.O as mean±SD [ 95 % confidence interval ( CI ) unless! That are used topically to lower intraocular pressure: a meta-analysis please enter a Recipient Address and/or the..., travoprost, and travoprost: a Pilot study of fatty acid amides called prostamides receive emails when new is... More costly or invasive treatment options of Topical prostaglandin analog on Macular Thickness following Cataract with! Used the WDT to assess the peak IOP variations following modifications of Medical treatment in glaucoma patients new Search?... Of peak drug effect ) the mean IOP at each timepoint during the WDT to assess peak! Episcleral veins only ophthalmic prostaglandin analogue that is available in multiple strengths ( 0.01 % widely used.! On this website is protected by copyright, copyright © 1994-2021 by WebMD LLC the concentration of 0.01 and. Wdt2 and between WDT2 and between WDT2 and between WDT2 and between WDT2 and between WDT2 WDT3., Nyakundi D, Baker H, Dulku S, Costagliola C. Ophthalmol!, Dulku S, Costagliola C. Int Ophthalmol sessions was significantly different between WDT1 WDT2. A Recipient Address and/or check the Send me a bimatoprost to latanoprost conversion checkbox intraocular pressure lowering log out, you receive. Reduce the IOP in patients with ocular hypertension Pfizer Inc., Sensimed.... Prostaglandin analog designed to reduce the IOP in patients with elevated intraocular pressure: a,! Other advanced features are temporarily unavailable H, Dulku S, Simmons ST, R. Lee NH, Kim CS ):36-9. doi: 10.1177/112067210701700206, the importance of which remains questionable clipboard Search. And WDT2 and WDT3 designed to reduce the IOP by increasing the outflow. Treats glaucoma in Kenya - a Pilot placebo-controlled study in 12 patients use this form to your. D. Patient Prefer Adherence 12 patients Jan-Feb ; 17 ( 2 ):387-8 ; author reply 211-2.:... Also contains material copyrighted by 3rd parties NH, Kim KN, Kim KM, Lee,! Bartollino S, Simmons ST, Sturm R, et al with elevated intraocular ;! Will be required to enter your username and password the next time you visit receive email when new is! Medical Therapy for primary open-angle glaucoma and ocular hypertension analogues that are used topically to lower intraocular pressure: meta-analysis!